News | September 22, 2022
JB Pharma witness 20% growth in August 2022: IQVIA
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
The objective of this study is to evaluate the efficacy of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients.
Cytel has now established entities in Australia, Shanghai, Beijing, and Singapore, and plans to expand into Seoul and Tokyo in the coming years.
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
Subscribe To Our Newsletter & Stay Updated
